News

KSP , McLaren Health Care's Specialty Pharmacy, has earned full re-accreditation for specialty pharmacy from URAC through August 1, 2026. By achieving this status, KSP has demonstrated its commitment to quality care, enhanced process, patient safety and improved outcomes. With this designation, KSP will continue providing specialty agents for various diseases. The medications and therapeutic follow-up offered by KSP are for patients with complex diseases or whose care requires high-cost treatments. Phys...

The Utilization Review Accreditation Commission (URAC) has awarded KSP , McLaren’s Specialty Pharmacy, as a 2022 Pioneer in URAC’s Leaders in Performance Measurement (LPM) in their recognition program. This distinction shows that KSP has demonstrated a commitment to improving healthcare quality through performance measurement. As a specialty pharmacy, KSP provides needed medications and therapeutics at an affordable cost for patients with complex diseases or whose care requires high-cost treatments. Bei...

Effective May 1, 2023, KSP, McLaren's specialty pharmacy will be included in the Humana Limited Access Network and will be able to fill the following medications for our patients with Humana! Caprelsa (vandetanib) - Thyroid Cancer Gattex (teduglutide) - Short Bowel Syndrome Gavreto (pralsetinib) - Non-small Cell Lung Cancer / Thyroid Cancer Gilotrif (afatinib) - Non-small Cell Lung Cancer Ofev (nintedanib) - Pulmonary Fibrosis / Interstitial Lung Disease Promacta (eltrombopag) - Aplastic Anemia / Thromb...

KSP Specialty Pharmacy is pleased to announce Eric Keahey as its new account executive. Eric is currently rounding to all McLaren subsidiaries educating providers on the ease and usability of KSP, McLaren’s specialty pharmacy for specialty medication needs. He is working with Karmanos Cancer Center and McLaren Health Care providers to increase patient access to oncology specialty medications but also expanding access into rheumatology, immunology, gastroenterology, hepatitis, HIV and other complex disea...

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org . The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient education a...

KSP Specialty Pharmacy is pleased to announce that it has achieved accreditation through the Accreditation Commission for Health Care (ACHC) for its pharmacy services. Accreditation is a process through which health care organizations demonstrate compliance with national standards. Accreditation by ACHC reflects an organization’s dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. ACHC is a nonprofit organization that has stood as a symbol of qu...

The fight against cancer requires a team of experts and careful planning. We often think of the hardworking oncologists, nurses and physicians who treat patients during their cancer journey. Their roles are vital, but there are many other key players in the battle against this disease. The KSP Specialty Pharmacy team connects patients to crucial cancer-fighting drugs. Doing so requires knowledgeable service, logistical organization and compassion for each individual. During his treatment for leukemia at...

KSP Specialty Pharmacy (KSP) is pleased to announce that it has received full accreditation from the Utilization Review Accreditation Commission (URAC). This accreditation is valid for three years. The achievement serves as a key differentiator and independent validation of quality. With this designation, KSP is able to continue with its provision of specialty oral oncolytic agents. Additionally, it allows for the provision of agents in other specialized areas, such as HIV, gastroenterology, neurology a...